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Abstract
Background: Bacteriocin-producing lactic acid bacteria are commonly used as natural protective
cultures. Among them, strains of the genus Pediococcus are particularly interesting for their ability
to produce pediocin, a broad spectrum antimicrobial peptide with a strong antagonistic activity
against the food-borne pathogen Listeria monocytogenes. Furthermore, there is increasing interest
in isolating new bacteriocin-producing strains of human intestinal origin that could be developed
for probiotic effects and inhibition of pathogenic bacteria in the gut. In this work, we typed a new
strain, co-isolated from baby faeces together with a Bifidobacterium thermophilum strain, and
characterized its proteinaceous compound with strong antilisterial activity.
Results: The newly isolated strain UVA1 was identified as a Pediococcus acidilactici by carbohydrate
fermentation profile, growth at 50°C and 16S rDNA sequencing. The partially purified bacteriocin
was heat resistant up to 100°C, active over a wide range of pH (2 to 9) and susceptible to
proteolytic enzymes. The molecular weight, estimated by SDS-PAGE, was similar to that of
pediocin AcH/PA-1 (4.5 kDa). P. acidilactici UVA1 harboured a 9.5-kb plasmid that could be cured
easily, which resulted in the loss of the antimicrobial activity. Southern hybridization using the DIG-
labelled pedA-probe established that the bacteriocin gene was plasmid-borne as for all pediocin
described so far. Nucleotide sequence of the whole operon (3.5 kb) showed almost 100 % similarity
to the pediocin AcH/PA-1 operon. The mRNA transcript for pedA could be detected in P. acidilactici
UVA1 but not in the cured derivative, confirming the expression of the pedA-gene in UVA1. Using
a new real-time PCR assay, eleven out of seventeen human faecal samples tested were found to
contain pedA-DNA.
Conclusion: We identified and characterised the first pediocin produced by a human intestinal
Pediococcus acidilactici isolate and successfully developed a new real-time PCR assay to show the
large distribution of pedA-containing strains in baby faecal samples.
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Background
The lactic acid bacteria are an inhomogeneous group
which includes among others the genera Pediococcus, Ente-
rococcus,  Lactococcus,  Lactobacillus  and  Streptococcus.
Among the Pediococcus group, P. acidilactici and P. pen-
tosaceus are widely used for fermentation of food products
like vegetable and meat products. By production of
organic acids, resulting in pH decrease, they contribute to
control the microbial succession during fermentation.
They also act as protective cultures preventing the growth
of food-borne pathogens such as Listeria monocytogenes or
Staphylococcus aureus [1] and by doing this, they extend
storage life and enhance safety of food products [2,3].
Beside production of classical antimicrobial compounds
such as organic acids or hydrogen peroxide, the protective
effect also results from the production of bacteriocins [4].
Bacteriocins are ribosomally synthesized, small, heat-sta-
ble antimicrobial peptides produced by bacteria. Pediocin
AcH/PA-1 is the most studied class IIa bacteriocin (non
modified, nonlantibiotic peptides) and has potential for
use as food preservative, due to its strong antilisterial
activity [5]. Since amino-acid sequence determination of
the pediocin AcH/PA-1 in 1992 [6,7], several pediocin-
producing P. acidilactici and P. pentosaceus strains have
been screened from a large variety of plants and fruits [8],
but also from the gastrointestinal tract of poultry, ducks
and other animals [9-11]. Millette et al. [12] recently iso-
lated a strain of Pediococcus acidilactici from human faeces
which produces an unidentified antimicrobial proteina-
ceous compound. To our knowledge, no pediocin-pro-
ducing Pediococcus has been isolated so far from human
faeces and it is therefore unknown to which extent these
strains are widespread in the human intestinal microbiota
and contribute to the microbial balance of the complex
gut ecosystem.
Real-time PCR is a very sensitive and rapid molecular
method for the detection of specific genes in complex
samples. It is particularly suitable for measuring non cul-
tivable bacteria, because detection is independent of
growth conditions of the target organism [13]. It has for
example recently been used successfully on faecal samples
to assess the survival of Lactococcus lactis subsp. cremoris FC
after transit through the gastrointestinal tract [14] or to
detect the presence of noroviruses in clinical stool sam-
ples [15].
In this work, we report the identification of a new bacteri-
ocin-producing strain of Pediococcus acidilactici (UVA1),
which was co-isolated from baby faeces with the bacterio-
cinogenic strain Bifidobacterium thermophilum RBL67 [16].
The biochemical and genetic characterization of the anti-
microbial compound was performed. The distribution of
pedA-containing strains in human faeces was also investi-
gated using a newly designed real-time PCR assay target-
ing the pediocin structural gene.
Methods
Bacterial strains, and growth conditions and plasmid-
curing
Lactobacillus paracasei subsp. paracasei DSM5622T, Pedio-
coccus acidilactici DSM 20284T and Pediococcus pentosaceus
DSM 20336T (obtained from DSMZ GmbH, Braunsch-
weig, Germany) were used as reference strains for analysis
of the carbohydrate fermentation profile. Listeria ivanovii
HPB28 (obtained from the Health Protection Branch,
Health and Welfare, Ottawa, Canada) was used as indica-
tor strain for the detection of pediocin activity [17]. P. aci-
dilactici  UL5 (own culture collection) was used as
pediocin producer control [17]. Pediococcus acidilactici
UVA1 was previously isolated from human baby faeces as
a stable consortium with the Bifidobacterium strain RBL67
[16], which was recently identified as Bifidobacterium ther-
mophilum. Strain UVA1 was purified by subsequent selec-
tive plating and analysis of single colonies by genus-
specific probes (von Ah, unpublished). A non-bacteriocin
producing derivative of P. acidilactici UVA1, named bac-,
was obtained after curing by novobiocin treatment
(Sigma-Aldrich Chemie GmbH, Buchs, Switzerland, 0.1
µg ml-1) as already described [18]. Sixty colonies were
screened by the overlay method for absence of antimicro-
bial activity against L. ivanovii HPB28 and four mutants
producing no inhibition halo were detected. One of them
was purified on MRSC agar, consisting of MRS ([19]
Biolife, Milan, Italy) supplemented with 0.05 % L-
cysteine hydrochloride and 1.5 % agar, and propagated in
MRSC broth. The cell-free supernatant was checked for the
absence of antilisterial activity and absence of the pedA-
gene was confirmed by PCR.
All lactic acid bacteria were routinely grown overnight in
MRSC medium, with incubation at 37°C in anaerobic jars
with an atmosphere generation system (Oxoid Anaero-
Gen TM, Basel, Switzerland). L. ivanovii HPB28 was prop-
agated in TSY medium consisting of tryptic soy broth
(Oxoid) containing 0.6 % (w/v) yeast extract (Merck,
Darmstadt, Germany) overnight at 30°C. For agar plates
and soft-agar, the media were supplemented with 1.5 %
and 0.75 % (w/v) agar, respectively. Bacterial stocks were
stored at -80°C in appropriate media supplemented with
33 % (v/v) glycerol and subcultured three times at one day
intervals on fresh agar plates before use. Cultures were
routinely checked under a light microscope for contami-
nation.
Carbohydrate fermentation profile
The carbohydrate fermentation profile of strain UVA1 was
determined using API 50 fermentation strips (BioMérieux,
Marcy l'Etoile, France). A 2-ml volume of an overnightBMC Biotechnology 2007, 7:55 http://www.biomedcentral.com/1472-6750/7/55
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culture (16 h) was centrifuged at 14'000 × g for 5 min at
4°C. The pellet was washed once and resuspended in 1 ml
of sterile, double distilled water. The suspension was then
added to 5 ml of CHL 50 medium (prepared according to
the manufacturer's instructions). Each tube of the API
CHL50 strips was then inoculated with 100 µl of the bac-
terial suspension in CHL50 medium and sealed with ster-
ile paraffin. The strips were incubated at 37°C under
anaerobic conditions, the results were visually assessed
after 24, 48 and 72 h and analysed with the APILAB+ soft-
ware version 3.3.3 according to the manufacturer's
instructions. P. acidilactici UL5, P. acidilactici DSM20284T,
P. pentosaceus DSM20336T, and L. paracasei subsp. paraca-
sei DSM5622T were used as reference strains. All tests were
repeated three times.
Determination of growth at 50°C
Strain UVA1 was incubated at 50°C in 20 ml MRSC
medium inoculated with 1 % of an overnight culture. P.
acidilactici  UL5 and DSM20284T  and  P. pentosaceus
DSM20336T were used as controls. The optical density at
600 nm was measured with an Uvikon 810P photometer
(Kontron Instruments, Rotkreuz, Switzerland) after 4, 24
and 96 h. The ability to grow at 50°C was positive if
OD600 exceeded 0.4 after 96 h. OD600 of 0.4 was set as the
limit of growth and corresponded to twice the value of the
OD of freshly inoculated medium. All tests were per-
formed twice.
Inhibition assay
Antibacterial activity was assessed by the agar-well diffu-
sion method. Briefly, 25 ml of soft-agar (heated at 45°C)
was inoculated with 0.1 % of an overnight culture of the
indicator strain L. ivanovii HBP28, poured into a Petri dish
and allowed to set for 30 min at room temperature. Holes
(diameter of 7 mm) were then punched in the agar and
filled with 80 µl of sample. The plates were incubated at
4°C for 30 min to allow bacteriocin diffusion and over-
night at 30°C for growth of the indicator strain. The diam-
eter of the inhibition zone was measured.
Effect of temperature, pH, enzymes and other agents on 
bacteriocin activity
Cell-free supernatant (CFS) was obtained after centrifuga-
tion at 13'000 g for 10 min at 4°C of a 16-h culture in
MRSC at pH 6 and 37°C. The supernatant was heated 5
min at 95°C. The effect of temperature on the antibacte-
rial activity was tested after heating at 121°C for 15 min
in an autoclave and at 100°C for 60 and 40 min using a
water-bath. The effect of pH was tested by adjusting the
pH of the CFS to values in a range from 2 to 11 using
either 1 M HCl or 1 M NaOH. Residual activity was meas-
ured by the agar-well diffusion method, after one day, one
week and one month storage at 4°C. To test the sensitivity
to proteases and other agents, the CFS was incubated for
2 h at 37°C in the presence of 1 mg ml-1 chymotrypsin,
pepsin, protease, proteinase K, trypsin or lysozyme or 1 %
SDS, urea, catalase, RNAse A, Tween 20, Tween 80, Triton-
X or 2, 5 or 10 mM EDTA. For enzyme denaturation, the
samples were finally heated at 95°C for 5 min and resid-
ual activity was measured by the agar-well diffusion
method. All enzymes and other chemicals were purchased
from Sigma-Aldrich Chemie GmbH (Buchs, Switzerland),
except proteinase K and trypsin, which were obtained
from Applichem (Darmstadt, Germany). Residual activity
was defined as the ratio of the diameter of the halo pro-
duced by the treated sample compared to the untreated
control and expressed in percentage. All assays were per-
formed twice
Molecular weight determination
The bacteriocin produced by P. acidilactici UVA1 was par-
tially purified by injecting 300 ml CFS at a rate of 1 ml
min-1 in a 60-ml SP Sepharose column connected to a
FPLC chromatography system (Ätka Purifier 10, Amer-
sham, Otelfingen, Switzerland). The column was first
equilibrated with 10 column volumes of 5 mM ammo-
nium acetate buffer (pH 5.0), 5-ml fractions were col-
lected in a fraction collector (Frac-950, Amersham) and
the bacteriocin-like activity was eluted with 0.45 M NaCl
in the same buffer. The CFS and active fractions after FPLC
were 10-fold concentrated by ultrafiltration (cutoff of 3
kDa) and 15 µl of the samples were loaded on two parallel
SDS gels, along with 10 µl of Polypeptide SDS-PAGE
molecular weight standard (BioRad Laboratories AG,
Reinach, Switzerland). The gels were prepared according
to Schägger and Jagow [20] and consisted of a 10 % acry-
lamide-bisacrylamide stacking gel and a 16.5 % separat-
ing gel. Separation was done with constant voltage (100
V) for 2 h 30 using a vertical slab gel apparatus (BioRad
Laboratories). One of the gels was stained with Coomas-
sie brilliant blue R250 (LK Bromma, Villeneuve-la-
Garenne, France) and the other was used for activity detec-
tion: the gel was first soaked for 2 h in fixation solution
(20 % isopropanol, 10 % acetic acid) and rinsed overnight
in HPLC-grade water before being overlaid with 25 ml soft
TSY agar inoculated with 0.1 % of an overnight culture of
L. ivanovii HBP28. The molecular weight was estimated by
comparison of the mobility of the inhibition zone to that
of the molecular weight marker run simultaneously. The
whole procedure was repeated twice.
DNA sequencing and PCR conditions
Sequencing of DNA was performed by Microsynth (Bal-
gach, Switzerland) and similarity searches were conducted
with the BLAST program from NCBI (version 2.2.15).
Primers and probe used in this study are listed in Table 1.
They were designed with the program Primer3 [21] and
synthesised by Microsynth. The PCR reactions were set up
in a total volume of 50 µl containing 2.5 U EuroTaq-DNA-BMC Biotechnology 2007, 7:55 http://www.biomedcentral.com/1472-6750/7/55
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Polymerase (Digitana, Horgen, Switzerland), 1.5 mM
magnesium chloride (Digitana), 0.2 mM dNTP's (GE
Healthcare), 0.5 µM of each primer and either 2 µl of DNA
or 40 µl of cell suspension (prepared by resuspending a
single colony in 210 µl of sterile, double distilled water).
The 16S rDNA of P. acidilactici UVA1 and UL5 were ampli-
fied using a slightly modified protocol from Schürch [22].
The annealing temperature for the bak11w/bak4 primers
was increased to 62°C. The 16s rDNA sequences of UVA1
and UL5 are deposited at GenBank under accession num-
bers [GenBank: EF059986] and [GenBank: EF059987],
respectively. For the amplification and sequencing of the
first 711 bp of the pediocin PA-1 operon, primers P1 and
P2 and conditions described by Rodriguez et al. [23] were
used. The second part of the operon (2864 bp) was ampli-
fied with primers pedopF and pedopR, designed on the
basis of the reported sequence for pSRQ11 [24]. Amplifi-
cation conditions were as follow: 2 min at 95°C, 30 cycles
of 1 min at 94°C, 35 s at 45°C and 3 min at 72°C and
final elongation step 7 min at 72°C. Oligonucleotides
pedopF and pedopR as well as pedseq A, B, C and D,
designed every 500 bp along the PCR product, were used
as sequencing primers. Additionally, a 1009-bp sequence
directly upstream and a 1417-bp sequence directly down-
stream of the operon were amplified and sequenced with
primer pairs pedseq L and H and pedseq M and N, respec-
tively. Amplification conditions were: 3 min at 95°C, 30
cycles of 1 min at 95°C, 35 s at 55°C and 2 min at 72°C
and final elongation step 7 min at 72°C.
Plasmid isolation and Southern blotting
Extrachromosomal DNA elements were extracted from P.
acidilactici UVA1, UL5 and the bac- mutant using a modi-
fied method after Anderson and McKay for small scale
plasmid isolation [25]. Shortly, for cell lysis, 9.5 µl
mutanolysin (1500 U ml-1 Sigma-Aldrich Chemie GmbH)
was added to the lysis solution (solution B) and plasmid
DNA was resuspended in 1 × TE buffer. Finally, the RNA
was digested with 10 µg RNase A (Sigma-Aldrich Chemie
GmbH). The DNA was visualized after electrophoresis on
a 0.65 % agarose gel in 1 × TBE at 100 V for 1 h 30. The
supercoiled DNA ladder (Promega, Madison WI, USA)
was used as size standard. DIG-labelling of the pedA-probe
(P1-P2 PCR product on P. acidilactici UVA1), blotting on
nylon membrane, hybridisation (at 42°C) and chemilu-
minescent detection were conducted with the DIG-High
Prime DNA Labeling and Detection Starter Kit II (Roche
Diagnostics, Rotkreuz, Switzerland) according to sup-
plier's instructions. Plasmid preparation, blotting and
hybridization were performed twice.
RNA isolation and reverse transcription
The RNA was isolated during the exponential growth-
phase of P. acidilactici UVA1, bac-, UL5 and DSM 20284T,
and P. pentosaceus DSM 20336T using the RNeasy Mini kit
(Qiagen, Basel, Switzerland). The protocol was slightly
modified by addition of 20 U mutanolysin in the lysis
solution. The samples were finally treated with RNase-free
DNAse I (Invitrogen, Basel, Switzerland) for 30 min at
37°C. First strand cDNA synthesis was performed with the
Omniscript reverse transcription kit (Qiagen) and 5 µl of
the product were used for PCR amplification of a 100 bp-
fragment with primers pedA2RTF and pedA2RTR. PCR
products were separated on a 2 % agarose gel in 1 × TAE
buffer by electrophoresis at 90 V for 2 h 30. The low
molecular weight DNA ladder and Tridye 100 bp DNA-
ladder (New England BioLabs, Ipswich, MA, USA) were
used as size standards.
Preparation of DNA from faecal samples
Twenty-one human faecal samples were collected in col-
laboration with the Department of Gastroenterology
(Hospital for Sick Children, Zurich, Switzerland). Thir-
teen faecal samples were collected from children donors
aged one month to 3 years and 4 from adults. Faecal sam-
ples were collected within 1 h after defecation, placed in
anaerobic jars and rapidly transported to our laboratory.
They were immediately frozen at -20°C upon arrival, i.e.
no more than 3 h after defecation. Total DNA was isolated
from 200 mg of each sample using the QIAamp DNA
Stool Mini kit (Qiagen) according to the manufacturer's
instructions. Before DNA extraction, one faecal sample
was autoclaved twice (121°C, 15 min) to obtain a sample
free of DNA. Ten aliquots of this sample were spiked with
a 10-fold serial dilution of P. acidilactici UVA1 (overnight
culture in MRSC) at concentrations ranging from 109 to
101 bacteria cells per g faeces. The extracted DNA was
stored at -20°C.
Real-time PCR
Primers and TaqMan probe listed in Table 1 were
designed based on the pedA sequence with the software
PrimerExpress 1.5 (Applied Biosystems, Rotkreuz, Swit-
zerland) and synthesized by Microsynth. The TaqMan
probe was labeled with 5'-FAM as a fluorescent reporter
dye and 3'-TAMRA as a quencher. Their specificity was
tested using the BLAST program from NCBI. Reactions
were set in a total volume of 25 µl, containing 2.5 µl of
faecal DNA extract, 12.5 µl of qPCR MasterMix from Euro-
gentec (Seraing, Belgium), 0.3 µM of each primer and 0.1
µM of the TaqMan probe. Reactions were run on an ABI
PRISM 7700 Sequence Detector (Applied Biosystems,
Rotkreuz, Switzerland). The amplification conditions
were 2 min at 50°C, 10 min denaturation at 95°C, fol-
lowed by 45 cycles of 15 sec at 95°C and 1 min at 60°C.
The cycle threshold (Ct), corresponding to the number of
cycle after which the target-DNA concentration increase
become exponential, was monitored. Results were ana-
lysed using the SDS 2.1 Software (Applied Biosystems).BMC Biotechnology 2007, 7:55 http://www.biomedcentral.com/1472-6750/7/55
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All reactions were done in triplicate and repeated three
times.
Results
Phenotypic identification of strain UVA1 as Pediococcus 
acidilactici
A carbohydrate fermentation profile was performed using
API 50 CHL strips after 72 h anaerobic incubation at
37°C. Using the APILAB+ software and P. acidilactici
DSM20284T, P. acidilactici UL5 (pediocin-producer) and
P. pentosaceus DSM20336T as control strains, UVA1 was
identified as Pediococcus acidilactici. Strains UVA1, UL5
and DSM20284T differed from each other. Mannose was
fermented by UL5 and DSM20284T but not by UVA1. Sac-
charose was only fermented by UL5 and DSM20336T
whereas D-trehalose was only fermented by DSM20284T
and DSM20336T. Using optical density measurement at
600 nm after 96 h incubation, strain UVA1, as well as P.
acidilactici DSM20284Tand UL5, were shown to grow at
50°C, whereas P. pentosaceus DSM20336T didn't.
Genotypic confirmation of the identity of P. acidilactici 
UVA1
The 16S rDNA sequences of strain UVA1 and P. acidilactici
UL5 were analysed using the software BioEdit [26]. The
assembly of sequence fragments produced a 1492 and
1568 bp sequences for strains UVA1 and UL5, respec-
tively. The sequences, compared with 16S rDNA
sequences in the GenBank, showed 99 % similarity with
the type strain Pediococcus acidilactici DSM20284T. The
results of 16S rDNA sequencing identified strain UVA1 as
a new Pediococcus acidilactici strain. Furthermore, the 16S
sequences of strains P. acidilactici UVA1 and UL5 were also
99% similar, showing a close relationship between these
two strains.
Biochemical characterization of the antimicrobial 
compound produced by P. acidilactici UVA1
Heating the cell-free supernatant (CFS) at 121°C for 15
min destroyed the inhibitory activity against Listeria
ivanovii HPB28, whereas heat treatments at 100°C for 40
and 60 min only yielded a slight reduction of the activity
with 80 and 75 % residual activity, respectively. Activity
remained unaffected after one month storage at 4°C at pH
values from 2 to 8. At pH 10 and 11, total loss of activity
was already observed after 1 week storage and only 60%
of the initial activity was still measurable after 1 month at
pH 9. Treatment with proteolytic enzymes such as chymo-
trypsin, pepsin, protease, proteinase K or trypsin resulted
in a total loss of activity while lysozyme, catalase and
other agents tested had no effect.
Determination of the molecular weight
As shown in Figure 1, SDS-PAGE of the partially purified
bacteriocin (concentrated active FPLC-fraction) showed a
diffuse band on the Coomassie-stained gel while a clear
inhibition halo was visible on the activity-gel for the con-
centrated FPLC-fraction as well as for the CFS. The relative
mobility of the inhibition zone on the gel overlaid with
Listeria ivanovii HBP28 was compared to that of the stand-
ards stained with Coomassie blue. The apparent molecu-
lar weight of the bacteriocin was estimated in the range of
4.5 to 5 kDa. The biochemical properties and the molecu-
lar weight described above, as well as the fact that this pro-
teinaceous compound is produced by a Pediococcus strain
suggest that the anti-Listeria compound is a pediocin-like
Table 1: Primers and probe used in this study
Primer/probe Target/specificity Sequence (5'-3') Product size (bp) Reference
Bak11w 16S rDNA AGT TTG ATC MTG GCT CAG [35]
Bak4 AGG AGG TGA TCC ARC CGC A [36]
P1 pedA-pedB AAA ATA TCT AAC TAA TAC TTG
P2 TAA AAA GAT ATT TGA CCA AAA 711 [23]
pedopF pedB-pedD GGG CGA GTT TAA CAT GCT AGA
pedopR TGA TTA TGA ATT AAC CGT GCA 2862 This study
pedseqA Sequencing of the pediocin operon CTT GCT CGA TAA TGG TAA
pedseqB CTA TCA GGT AAC TGA AAA
pedseqC CAC GCT TTT CTG ATG CAA
pedseqD TTC TTG ACC CCA TTA GAA This study
pedseqL Upstream of operon AGC AAT TAC AGT CAA CCA TAA CCA T
pedseqH ACA GAG CAG GAA TGT TTG CCA CAA G 1009 This study
pedseq M Downstream of operon ATT GTC TCC GGC ACA ATG TT
pedseqN CAA AGT GGG GAA ACT CGA AA 1417 This study
pedA2RTF Real-time PCR GGC CAA TAT CAT TGG TGG TA
pedA2RTR ATT GAT TAT GCA AGT GGT AGC C
TqM-pedA FAM-ACT TGT GGC AAA CAT TCC TGC 
TCT GTT GA-TAMRA
100 This studyBMC Biotechnology 2007, 7:55 http://www.biomedcentral.com/1472-6750/7/55
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bacteriocin. A genetic approach was used to confirm this
assumption.
Genetic characterization of the bacteriocin
Primers P1 and P2 were used to amplify and sequence a
711-bp fragment (from 91 bp upstream of pedA to 33 bp
downstream of the translational start of pedC [GenBank:
M83924]) including the ribosome binding site as well as
the -35/-10 region. The remaining sequence of the operon
(2862 bp, from 13 bp upstream the end of pedB to the end
of pedD) was amplified with primers pedopF and pedopR
(Table 1) and the generated DNA fragment was
sequenced. This resulted in a 3473-bp sequence, compris-
ing the four genes constituting the operon including the
upstream region of pedA (91 bp), presumably containing
the regulatory elements of the operon. The whole nucle-
otide sequence showed more than 99.5 % similarity to the
published sequences for P. acidilactici K1 [GenBank:
AY705375], P. acidilactici H [GenBank: U02482], P. acidi-
lactici PAC1.0 [GenBank: M83924], P. pentosaceus [Gen-
Bank: AY316525],  Lactobacillus plantarum [GenBank:
AY316526], P. parvulus [GenBank: AY316524], and Bacil-
lus coagulans [GenBank: AF300457]. Two sequences of
1009 and 1417 bp, upstream and downstream of the
operon, respectively, were also PCR-amplified and
sequenced. The resulting 5368-bp sequence was 99 %
identical to the pediocin-encoding plasmid pSRQ11
described for P. acidilactici PA-1 [27].
The antimicrobial activity is linked to the presence of the 
plasmid and the expression of pedA
Agarose gel electrophoresis of plasmid DNA preparation
from strain UVA1 showed three bands: two extrachromo-
somal DNA elements at 9.5 kb and at >10 kb and one cor-
responding to chromosomal DNA, respectively (Figure
2(a)). For strain bac-, a non-inhibitory derivative of P. aci-
dilactici UVA1 obtained after plasmid curing, in contrast,
only chromosomal DNA was visible. Plasmid DNA pre-
pared from the control pediocin producing strain UL5
exhibited the same bands as detected for UVA1, in addi-
tion to two larger extrachromosomal DNA elements.
Southern hybridization with the pedA-probe (Figure 2(b))
yielded positive signals for the 9.5-kb and the >10-kb
extrachromosomal elements present in UL5 and UVA1,
but no hybridization occurred for bac-, confirming the
presence of the pedA-gene on the 9.5-kb plasmid, the band
at >10 kb probably being the relaxed circular form of the
same plasmid. The presence of the pedA-gene on the plas-
Molecular weight determination of the bacteriocin produced by strain UVA1 Figure 1
Molecular weight determination of the bacteriocin produced by strain UVA1. (a) Coomassie stained SDS-PAGE gel. 
(b) SDS gel overlaid with the indicator strain Listeria ivanovii HPB28. Std: polypeptide molecular weight standard in kDa, F3c: 
active FPLC-fraction 10-fold concentrated. CFSc: cell-free supernatant of a UVA1 culture, 10-fold concentrated. CFS: cell-free 
supernatant not concentrated.
14.4
Std F3c   CFSc CFS         F3c CFSc CFS
26.6
17.0
6.5
3.5
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mid was confirmed by an agar-well diffusion assay, where
the supernatant of a culture of the bac- strain failed to
exhibit inhibition of the indicator strain Listeria ivanovii
HPB28 (Figure 2(c) and 2(d)). Furthermore, the pedA-
transcript was detected by reverse-transcription-PCR on
cDNA from P. acidilactici UVA1 (Figure 3, lanes 7–9) but
not from the cured derivative bac- (Figure 3, lanes 1–3),
providing the ultimate link between presence of the plas-
mid-localized genetic determinant and expression of the
bacteriocin. The presence of a slight band at 100 bp for the
non-plasmid containing strains (Figure 3, lanes 1–4)
could not be explained, but the very weak intensity com-
pared to lanes 7 to 9 does not represent a positive signal.
A second PCR, performed with primers P1 and P2 (Table
1), which encompass the regulatory region upstream of
the transcriptional start, resulted in no amplification in
samples using cDNA as template, allowing us to exclude
genomic DNA contamination in the RNA preparation of
UVA1, UL5 and P. pentosaceus DSM 20336T (data not
shown).
Distribution of pedA-containing strains in human faecal 
samples
The designed primers and probe allowed specific amplifi-
cation of a 100-bp fragment located within the pedA-gene.
As determined with spiked samples, the reaction was lin-
ear for concentrations ranging from 109 to 105 of P. acidi-
lactici UVA1 cells per g of spiked faeces, corresponding to
Ct values comprised between 22 and 35 (Figure 4(a)). A
Ct value of 35 was thus fixed as the upper limit for detec-
tion. Samples with a higher value were considered not to
contain any pedA-gene. With this assay, the pediocin gene
was detected in DNA isolated from 11 out of 13 children
faecal samples tested, but in none of the 4 adult samples
(Figure 4(b)).
Discussion
Data obtained from phenotypic characterization indi-
cated that strain UVA1 is a Pediococcus acidilactici. The car-
bohydrate fermentation profile matched that described
for P. acidilactici in the APILAB+ database and in the liter-
ature [8]. Furthermore, among Pediococcus species, only P.
acidilactici  is able to grow at 50°C [8]. It is currently
accepted that the phenotypic characterization of a strain is
not enough to discriminate species or even strains and a
polyphasic approach for species identification is recom-
mended [28]. The genotypic characterization using 16S
rDNA sequence analysis confirmed the data from the phe-
notypic characterization, with strain UVA1 showing more
than 99 % similarity to the 16S sequences of other P. aci-
dilactici strains. Mora et al. 2000 [29] used restriction frag-
ment length polymorphism (RFLP) of housekeeping
genes and 16S rDNA sequence analysis to distinguish
between pediocin- and non-pediocin-producing P. acidi-
Localization of the pedA gene on the plasmid by curing and Southern blotting Figure 2
Localization of the pedA gene on the plasmid by curing and Southern blotting. (a) Agarose gel electrophoresis of 
plasmid DNA. UVA1: P. acidilactici UVA1. UL5: P. acidilactici UL5. bac-: cured derivative of UVA1. M. Supercoiled DNA ladder in 
kb. ch: chromosomal DNA band. (b) Southern blot DNA hybridization of the DIG labeled pedA-probe with plasmidic DNA 
from P. acidilactici bac-, UVA1 and UL5. (c) and (d) Agar-well diffusion assay with CFS of cultures of P. acidilactici UVA1 (c) and 
its cured derivative P. acidilactici bac- (d).
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lactici  strains and showed that the pediocin-producing
strains represented a homogenous subpopulation. This is
supported by our observation that strains UVA1 and UL5,
two pediocin-producing Pediococcus acidilactici, are very
closely related in regard to 16S sequence similarity.
P. acidilactici UVA1 inhibited L. ivanovii HPB28 by pro-
duction of a proteinaceous compound, as demonstrated
by the total loss of activity after proteolytic treatments.
This compound had a molecular weight of approximately
4.5 kDa, similar to pediocin PA-1. This was confirmed by
the detection in strain UVA1 of a plasmid of approxi-
mately 9.5 kb, on which we could localize the pedA-gene.
We also found that the pediocin operon, which consists of
the pediocin structural gene (pedA), the specific immunity
gene (pedB), and genes required for processing, matura-
tion and secretion of the bacteriocin (pedC  and  D),
showed 99 to 100 % similarity to the published sequences
for the pediocin PA-1/AcH operon [24,27]. In all pedi-
ocin-producing strains isolated so far, the genetic determi-
nants are plasmid-encoded [5]. The comparison of genetic
determinants of many pediocin-like producer strains [30]
showed that all pediocin genes were carried by plasmids,
but the surrounding sequences on the plasmids can differ
from one strain to the other. Sequencing data for the
regions upstream the regulatory region and downstream
the transcription terminator of the pediocin operon in
UVA1 suggested that the plasmid harboured by P. acicilac-
tici UVA1 is probably identical to pSRQ11, a 9.4 kb plas-
mid from P. acidilactici PA-1 [24].
Transcription analysis by reverse-transcription PCR using
primers specific for the mRNA transcript of a particular
protein is a straightforward method to establish the link
between the presence of the genetic determinant and the
observed protein activity. With this direct method, we
could show that the pedA-transcript was synthesized in
exponentially growing cells of UVA1 but not in the cured,
Real-time PCR on faecal DNA samples Figure 4
Real-time PCR on faecal DNA samples. (a) Ct values of 
spiked samples plotted against spiked cell concentration in 
faecal DNA sample. (b) Ct values obtained for children (C1-
C13) and adult (A1-A4) faecal samples. F0: faecal sample free 
of DNA. w: water instead of DNA. Values represented are 
means and standard deviations for 3 repetitions.
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Transcription analysis of pedA Figure 3
Transcription analysis of pedA. pedA-reverse transcription-PCR on cDNA from P. acidilactici bac- (1, 2, 3) or UVA1 (7, 8, 9) 
after 1 h 30, 2 h 30 and 3 h 30 of growth, respectively, and from P. acidilactici DSM 20284T(4) or UL5 (6) and P. pentosaceus 
DSM 20336T (5) after 2 h 30 of growth. 10: water instead of DNA. lm: low molecular weight DNA ladder (in bp). h: Tridye 
100-bp DNA ladder (in bp). Expected product size: 100 bp.
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non-active derivative, bac-, and that the inhibitory activity
of UVA1 was due to pediocin production. It is also inter-
esting to notice that in P. pentosaceus DSM 20336T, the
pedA-gene and the mRNA transcript were detected, but no
inhibitory activity was observed against L. ivanovii HPB28
and the PCR with primers pedopF and pedopR did not
yield any product (data not shown). Diep et al. [31]
reported similar observations in P. pentosaceus ATCC
25745, where a truncated pen locus lead to low expression
of antimicrobial activity.
Pediococci are commonly associated with various plants
and their products or meat [8,32].) There are only few
reports on pediococci detected in human faeces or gastroin-
testinal tract [12,33,34], and only Millette et al. [12],
reported the presence of an antibacterial compound of
proteinaceous nature, although not identified yet. Strain
UVA1 is, to our knowledge, the first pediocin-producing
Pediococcus  to be isolated from human faecal material,
which characteristic could be particularly interesting for
the food industry for biopreservation as well as for possi-
ble probiotic effect. In this work, we showed, with a new
real-time PCR assay, that strains containing the pedA-gene
are relatively widespread in baby faecal material, but were
not found in the 4 adult samples tested. Therefore, human
faecal material could be a good source for isolating new
pediocin-producing strains.
Conclusion
Strain UVA1, isolated from new born faeces, was clearly
identified as a Pediococcus acidilactici using a polyphasic
approach. Data for the molecular size, sensitivity to pro-
tease and sequence of the plasmid-borne genetic determi-
nant indicated that the antibacterial compound produced
by UVA1 is pediocin PA-1/AcH. To our knowledge, Pedio-
coccus acidilactici UVA1 is the first pediocin-producing
Pediococcus strain isolated from human faeces. Real-time
PCR was an efficient method for detection of specific
genes in faecal samples harbouring a complex microbiota.
We showed a large distribution of pedA-containing strains
in baby faecal samples.
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